Corvus Pharmaceuticals, Inc. SC 13D and SC 13D/A reports

Location
863 Mitten Road, Suite 102, Burlingame, CA
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/17/2024, 01:25 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report AMENDMENT NO. 9 May 8, 2024
SC 13D/A Report AMENDMENT NO. 8 Nov 3, 2021
SC 13D/A Report AMENDMENT NO. 7 Sep 22, 2021
SC 13D/A Report AMENDMENT NO. 6 Aug 4, 2021
SC 13D/A Report AMENDMENT NO. 5 Feb 17, 2021
SC 13D/A Report AMENDMENT NO. 3 TO SCHEDULE 13D Jul 9, 2020
SC 13D/A Report AMENDMENT NO. 4 Apr 17, 2020
SC 13D/A Report SC 13D/A Jul 29, 2019
SC 13D/A Report AMENDMENT NO. 3 Jul 2, 2019
SC 13D/A Report SC 13D/A Jan 31, 2019
SC 13D Report SC 13D Mar 21, 2018
SC 13D/A Report AMENDMENT NO. 2 Mar 14, 2018
SC 13D/A Report AMENDMENT NO. 1 Jan 26, 2018
SC 13D Report | Data SCHEDULE 13D Apr 1, 2016
SC 13D Report | Data SC 13D Mar 30, 2016